Guang'an Bingde Pharmaceutical Co., Ltd

Guang'an Bingde Pharmaceutical Co., Ltd. was established on May 18, 2018, with a registered capital of 23 million yuan. It covers an area of 63.9 acres and has a factory area of over 23000 square meters. It is a limited liability company dedicated to the research and development, production, and sales of chemical drug raw materials and pharmaceutical intermediates. Relying on the scientific research team of Professor Zheng Hu, Dean of the School of Original Medicine of Sichuan University, and the Chemical Medicine Research Office of Sichuan University, we carry out the most cutting-edge research on domestic biopharmaceuticals and chemical synthetic drugs. We have many senior experts who have been engaged in the industry for 30 years, who are outstanding in the first-line clinical use of tuberculosis drugs rifamycin. In addition to making major breakthroughs in rifampicin production process, we also research and produce new derivatives rifamycin series products, such as rifapentin, rifabutin, rifamycin sodium, rifaximin, and other anti tuberculosis products. Some products are produced independently at home and abroad.